Skip to main content
SpringerLink
Log in

Myokarditis

  • Chapter
  • First Online:
Klinische Kardiologie

Part of the book series: Springer Reference Medizin ((SRM))

  • 1340 Accesses

Zusammenfassung

Eine Myokarditis kann sowohl im Rahmen von Infektionen als auch infolge von nichtinfektiösen Erkrankungen wie z. B. der Sarkoidose entstehen. Bei einem Großteil der durch Infektionen bedingten Myokarditiden kommt es zu einer spontanen Ausheilung der Erkrankung. Bei einem geringen Teil der Patienten/-innen mit Myokarditis kommt es allerdings zu einer chronisch progredienten Erkrankung mit konsekutiver Störung der myokardialen Funktion entsprechend dem klinischen Bild einer dilatativen Kardiomyopathie. Der Goldstandard für die Diagnose einer Myokarditis ist weiterhin die endomyokardiale Biopsie. Wichtig ist, dass die Myokardbiopsie histologisch, immunhistologisch und unter Verwendung molekularbiologischer Techniken auch virologisch exakt analysiert wird, um die verschiedenen Entitäten der Myokarditis exakt zu erfassen und dann mögliche kausale Therapieoptionen einleiten zu können. Als kausale Therapieoptionen stehen immunmodulatorische und antivirale Ansätze zur Verfügung.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 239.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Literatur

  • Anderson JL, Carlquist JF, Lutz JR, DeWitt CW, Hammond EH (1984) HLA A, B and DR typing in idiopathic dilated cardiomyopathy: a search for immune response factors. Am J Cardiol 53(9):1326–1330

    Article  PubMed  Google Scholar 

  • Arangalage D, Degrauwe N, Michielin O, Monney P, Ozdemir BC (2021) Pathophysiology, diagnosis and management of cardiac toxicity induced by immune checkpoint inhibitors and BRAF and MEK inhibitors. Cancer Treat Rev 100:102282. https://doi.org/10.1016/j.ctrv.2021.102282

    Article  PubMed  Google Scholar 

  • Bachelier K, Biehl S, Schwarz V, Kindermann I, Kandolf R, Sauter M, Ukena C, Yilmaz A, Sliwa K, Bock CT, Klingel K, Bohm M (2017) Parvovirus B19-induced vascular damage in the heart is associated with elevated circulating endothelial microparticles. PLoS ONE 12(5):e0176311. https://doi.org/10.1371/journal.pone.0176311

    Article  PubMed  PubMed Central  Google Scholar 

  • Bang V, Ganatra S, Shah SP, Dani SS, Neilan TG, Thavendiranathan P, Resnic FS, Piemonte TC, Barac A, Patel R, Sharma A, Parikh R, Chaudhry GM, Vesely M, Hayek SS, Leja M, Venesy D, Patten R, Lenihan D, Nohria A, Cooper LT (2021) Management of patients with giant cell myocarditis: JACC review topic of the week. J Am Coll Cardiol 77(8):1122–1134. https://doi.org/10.1016/j.jacc.2020.11.074

    Article  PubMed  Google Scholar 

  • Brambatti M, Matassini MV, Adler ED, Klingel K, Camici PG, Ammirati E (2017) Eosinophilic myocarditis: characteristics, treatment, and outcomes. J Am Coll Cardiol 70(19):2363–2375. https://doi.org/10.1016/j.jacc.2017.09.023

    Article  PubMed  Google Scholar 

  • Caforio AL, Mahon NJ, Tona F, McKenna WJ (2002) Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur J Heart Fail 4(4):411–417

    Article  PubMed  Google Scholar 

  • Caforio AL, Calabrese F, Angelini A, Tona F, Vinci A, Bottaro S, Ramondo A, Carturan E, Iliceto S, Thiene G, Daliento L (2007) A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J 28(11):1326–1333

    Article  PubMed  Google Scholar 

  • Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Helio T, Heymans S, Jahns R, Klingel K, Linhart A, Maisch B, McKenna W, Mogensen J, Pinto YM, Ristic A, Schultheiss HP, Seggewiss H, Tavazzi L, Thiene G, Yilmaz A, Charron P, Elliott PM, European Society of Cardiology Working Group on M, Pericardial D (2013) Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34(33):2636–2648, 2648a–2648d. https://doi.org/10.1093/eurheartj/eht210

    Article  PubMed  Google Scholar 

  • Cooper LT Jr, Berry GJ, Shabetai R (1997) Idiopathic giant-cell myocarditis – natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med 336(26):1860–1866

    Article  PubMed  Google Scholar 

  • Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kühl U, Levine GN, Narula J, Starling RC, Towbin J, Virmani R (2007) The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 116(19):2216–2233

    Article  PubMed  Google Scholar 

  • D’Ambrosio A, Patti G, Manzoli A, Sinagra G, Di Lenarda A, Silvestri F, Di Sciascio G (2001) The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 85(5):499–504

    PubMed  PubMed Central  Google Scholar 

  • Dennert R, Velthuis S, Schalla S, Eurlings L, van Suylen RJ, van Paassen P, Tervaert JW, Wolffs P, Goossens VJ, Bruggeman C, Waltenberger J, Crijns HJ, Heymans S (2010) Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load. Antivir Ther 15(2):193–201

    Article  PubMed  Google Scholar 

  • Dominguez F, Kühl U, Pieske B, Garcia-Pavia P, Tschöpe C (2016) Update on myocarditis and inflammatory cardiomyopathy: reemergence of endomyocardial biopsy. Rev Esp Cardiol (English Ed) 69(2):178–187. https://doi.org/10.1016/j.rec.2015.10.015

    Article  Google Scholar 

  • Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, White JA, Abdel-Aty H, Gutberlet M, Prasad S, Aletras A, Laissy JP, Paterson I, Filipchuk NG, Kumar A, Pauschinger M, Liu P (2009) Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol 53(17):1475–1487

    Article  PubMed  PubMed Central  Google Scholar 

  • Frustaci A, Russo MA, Chimenti C (2009) Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 30(16):1995–2002. https://doi.org/10.1093/eurheartj/ehp249

    Article  PubMed  Google Scholar 

  • Gilotra NA, Griffin JM, Pavlovic N, Houston BA, Chasler J, Goetz C, Chrispin J, Sharp M, Kasper EK, Chen ES, Blankstein R, Cooper LT, Joyce E, Sheikh FH (2022) Sarcoidosis-related cardiomyopathy: current knowledge, challenges, and future perspectives state-of-the-art review. J Card Fail 28(1):113–132. https://doi.org/10.1016/j.cardfail.2021.06.016

    Article  PubMed  Google Scholar 

  • Greulich S, Seitz A, Muller KAL, Grun S, Ong P, Ebadi N, Kreisselmeier KP, Seizer P, Bekeredjian R, Zwadlo C, Grani C, Klingel K, Gawaz M, Sechtem U, Mahrholdt H (2020) Predictors of mortality in patients with biopsy-proven viral myocarditis: 10-year outcome data. J Am Heart Assoc:e015351. https://doi.org/10.1161/JAHA.119.015351

  • Kasner M, Aleksandrov A, Escher F, Al-Saadi N, Makowski M, Spillmann F, Genger M, Schultheiss HP, Kuhl U, Pieske B, Morris DA, Noutsias M, Tschope C (2017) Multimodality imaging approach in the diagnosis of chronic myocarditis with preserved left ventricular ejection fraction (MCpEF): the role of 2D speckle-tracking echocardiography. Int J Cardiol 243:374–378. https://doi.org/10.1016/j.ijcard.2017.05.038

    Article  PubMed  Google Scholar 

  • Kindermann I, Kindermann M, Kandolf R, Klingel K, Bultmann B, Muller T, Lindinger A, Bohm M (2008) Predictors of outcome in patients with suspected myocarditis. Circulation 118(6):639–648

    Article  PubMed  Google Scholar 

  • Klingel K, Hohenadl C, Canu A, Albrecht M, Seemann M, Mall G, Kandolf R (1992) Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci U S A 89(1):314–318

    Article  PubMed  PubMed Central  Google Scholar 

  • Kühl U, Pauschinger M, Bock T, Klingel K, Schwimmbeck CP, Seeberg B, Krautwurm L, Noutsias M, Poller W, Schultheiss HP, Kandolf R (2003a) Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 108(8):945–950

    Article  PubMed  Google Scholar 

  • Kühl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M, Poller W, Schultheiss HP (2003b) Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107(22):2793–2798

    Article  PubMed  Google Scholar 

  • Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss HP (2005a) High prevalence of viral genomes and multiple viral infections in the myocardium of adults with „idiopathic“ left ventricular dysfunction. Circulation 111(7):887–893

    Article  PubMed  Google Scholar 

  • Kühl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, Schultheiss HP (2005b) Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112(13):1965–1970

    Article  PubMed  Google Scholar 

  • Kuhl U, Lassner D, von Schlippenbach J, Poller W, Schultheiss HP (2012) Interferon-Beta improves survival in enterovirus-associated cardiomyopathy. J Am Coll Cardiol 60(14):1295–1296. https://doi.org/10.1016/j.jacc.2012.06.026

    Article  PubMed  Google Scholar 

  • Lurz P, Luecke C, Eitel I, Fohrenbach F, Frank C, Grothoff M, de Waha S, Rommel KP, Lurz JA, Klingel K, Kandolf R, Schuler G, Thiele H, Gutberlet M (2016) Comprehensive cardiac magnetic resonance imaging in patients with suspected myocarditis: the MyoRacer-Trial. J Am Coll Cardiol 67(15):1800–1811. https://doi.org/10.1016/j.jacc.2016.02.013

    Article  PubMed  Google Scholar 

  • Lynge TH, Nielsen TS, Gregers Winkel B, Tfelt-Hansen J, Banner J (2019) Sudden cardiac death caused by myocarditis in persons aged 1–49 years: a nationwide study of 14,294 deaths in Denmark. Forensic Sci Res 4(3):247–256. https://doi.org/10.1080/20961790.2019.1595352

    Article  PubMed  PubMed Central  Google Scholar 

  • Mahfoud F, Gartner B, Kindermann M, Ukena C, Gadomski K, Klingel K, Kandolf R, Bohm M, Kindermann I (2011) Virus serology in patients with suspected myocarditis: utility or futility? Eur Heart J 32(7):897–903. https://doi.org/10.1093/eurheartj/ehq493

    Article  PubMed  Google Scholar 

  • Manapragada PP, Andrikopoulou E, Bajaj N, Bhambhvani P (2021) PET cardiac imaging (perfusion, viability, sarcoidosis, and infection). Radiol Clin N Am 59(5):835–852. https://doi.org/10.1016/j.rcl.2021.05.009

    Article  PubMed  Google Scholar 

  • Mason JW, O’Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE (1995) A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 333(5):269–275

    Article  PubMed  Google Scholar 

  • Maurer MS, Sultan MB, Rapezzi C (2019) Tafamidis for transthyretin amyloid cardiomyopathy. N Engl J Med 380(2):196–197. https://doi.org/10.1056/NEJMc1814074

    Article  PubMed  Google Scholar 

  • Mavrogeni S, Koutsogeorgopoulou L, Karabela G, Stavropoulos E, Katsifis G, Raftakis J, Plastiras S, Noutsias M, Markousis-Mavrogenis G, Kolovou G (2017) Silent myocarditis in systemic sclerosis detected by cardiovascular magnetic resonance using Lake Louise criteria. BMC Cardiovasc Disord 17(1):187. https://doi.org/10.1186/s12872-017-0619-x

    Article  PubMed  PubMed Central  Google Scholar 

  • McCarthy RE 3rd, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, Baughman KL (2000) Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342(10):690–695

    Article  PubMed  Google Scholar 

  • McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A (2021a) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599–3726. https://doi.org/10.1093/eurheartj/ehab368

    Article  PubMed  Google Scholar 

  • McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, Burri H, Butler J, Celutkiene J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A, Group ESCSD (2021b) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 00:001–128. https://doi.org/10.1093/eurheartj/ehab368

    Article  Google Scholar 

  • Movva R, Brown SB, Morris DL, Figueredo VM (2013) Anakinra for myocarditis in juvenile idiopathic arthritis. Tex Heart Inst J 40(5):623–625

    PubMed  PubMed Central  Google Scholar 

  • Neumann DA, Lane JR, Allen GS, Herskowitz A, Rose NR (1993) Viral myocarditis leading to cardiomyopathy: do cytokines contribute to pathogenesis? Clin Immunol Immunopathol 68(2):181–190. https://doi.org/10.1006/clin.1993.1116

    Article  PubMed  Google Scholar 

  • Norja P, Hokynar K, Aaltonen LM, Chen R, Ranki A, Partio EK, Kiviluoto O, Davidkin I, Leivo T, Eis-Hubinger AM, Schneider B, Fischer HP, Tolba R, Vapalahti O, Vaheri A, Soderlund-Venermo M, Hedman K (2006) Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci U S A 103(19):7450–7453

    Article  PubMed  PubMed Central  Google Scholar 

  • Noutsias M (2014) Myocarditis. In: Seferovic P (Hrsg) The experts approach – cardiomyopathies: practical recommendations to diagnosis and management. Oxford University Press, Oxford, S 423–439

    Google Scholar 

  • Noutsias M (2016) Myocarditis. In: Maisel AS, Filippatos G (Hrsg) Algorithms in heart failure, Bd 1. Jaypee Brothers Medical Publishers (P) Ltd, New Delhi, S 323–345

    Google Scholar 

  • Noutsias M, Maisch B (2014) Myocarditis and pericarditis. In: Tubaro M, Vranckx P, Price S, Vrints C (Hrsg) The ESC textbook of acute and intensive cardiac care 2e, Bd 2. Oxford University Press, Oxford, S 547–560

    Google Scholar 

  • Noutsias M, Tschope C (2016) Giant cell myocarditis: still a conundrum. The need for a worldwide registry. Eur J Heart Fail 18(12):1459–1461. https://doi.org/10.1002/ejhf.648

    Article  PubMed  Google Scholar 

  • Noutsias M, Seeberg B, Schultheiss HP, Kühl U (1999) Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy. Circulation 99(16):2124–2131

    Article  PubMed  Google Scholar 

  • Noutsias M, Pauschinger M, Schultheiss HP, Kuhl U (2003) Cytotoxic perforin+ and TIA-1+ infiltrates are associated with cell adhesion molecule expression in dilated cardiomyopathy. Eur J Heart Fail 5(4):469–479

    Article  PubMed  Google Scholar 

  • Noutsias M, Kühl U, Lassner D, Gross U, Pauschinger M, Schultheiss HP, Gutberlet M (2007) Parvovirus B19-associated active myocarditis with biventricular thrombi – results of endomyocardial biopsy investigations and cardiac magnetic resonance imaging. Circulation 115(13):e378–e380

    Article  PubMed  Google Scholar 

  • Noutsias M, Pauschinger M, Gross U, Lassner D, Schultheiss HP, Kuhl U (2008) Giant-cell myocarditis in a patient presenting with dilated cardiomyopathy and ventricular tachycardias treated by immunosuppression: a case report. Int J Cardiol 128(2):e58–e59

    Article  PubMed  Google Scholar 

  • Noutsias M, Rohde M, Goldner K, Block A, Blunert K, Hemaidan L, Hummel M, Blohm JH, Lassner D, Kuhl U, Schultheiss HP, Volk HD, Kotsch K (2011) Expression of functional T-cell markers and T-cell receptor Vbeta repertoire in endomyocardial biopsies from patients presenting with acute myocarditis and dilated cardiomyopathy. Eur J Heart Fail 13(6):611–618. https://doi.org/10.1093/eurjhf/hfr014

    Article  PubMed  Google Scholar 

  • Pauschinger M, Bowles NE, Fuentes-Garcia FJ, Pham V, Kühl U, Schwimmbeck PL, Schultheiss HP, Towbin JA (1999) Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 99(10):1348–1354

    Article  PubMed  Google Scholar 

  • Pauschinger M, Noutsias M, Kühl U, Schultheiss HP (2002) [Pericardial effusions, cardiac tamponade, armored heart. Preventing sequelae of pericarditis]. MMW Fortschr Med 144(14):41–42

    Google Scholar 

  • Pauschinger M, Hoppe K, Schwimmbeck PL (2003) Relevance of myocardial inflammation for the activation of matrix metalloproteinase expression in patients with inflammatory cardiomyopathy. Circulation 108(IV):24

    Google Scholar 

  • Pauschinger M, Chandrasekharan K, Schultheiss HP (2004) Myocardial remodeling in viral heart disease: possible interactions between inflammatory mediators and MMP-TIMP system. Heart Fail Rev 9(1):21–31

    Article  PubMed  Google Scholar 

  • Pelliccia A, Solberg EE, Papadakis M, Adami PE, Biffi A, Caselli S, La Gerche A, Niebauer J, Pressler A, Schmied CM, Serratosa L, Halle M, Van Buuren F, Borjesson M, Carre F, Panhuyzen-Goedkoop NM, Heidbuchel H, Olivotto I, Corrado D, Sinagra G, Sharma S (2019) Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC). Eur Heart J 40(1):19–33. https://doi.org/10.1093/eurheartj/ehy730

    Article  PubMed  Google Scholar 

  • Rigopoulos AG, Ali M, Abate E, Torky AR, Matiakis M, Mammadov M, Melnyk H, Vogt A, de Vecchis R, Bigalke B, Wohlgemuth W, Mavrogeni S, Noutsias M (2019) Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement. Heart Fail Rev 24(4):521–533. https://doi.org/10.1007/s10741-019-09776-3

    Article  PubMed  Google Scholar 

  • Rikhi R, Karnuta J, Hussain M, Collier P, Funchain P, Tang WHW, Chan TA, Moudgil R (2021) Immune checkpoint inhibitors mediated lymphocytic and giant cell myocarditis: uncovering etiological mechanisms. Front Cardiovasc Med 8:721333. https://doi.org/10.3389/fcvm.2021.721333

    Article  PubMed  PubMed Central  Google Scholar 

  • Robinson J, Hartling L, Vandermeer B, Crumley E, Klassen TP (2005) Intravenous immunoglobulin for presumed viral myocarditis in children and adults. Cochrane Database Syst Rev 1:CD004370

    Google Scholar 

  • Rutschow S, Leschka S, Westermann D, Puhl K, Weitz A, Ladyszenskij L, Jaeger S, Zeichhardt H, Noutsias M, Schultheiss HP, Tschope C, Pauschinger M (2010) Left ventricular enlargement in coxsackievirus-B3 induced chronic myocarditis – ongoing inflammation and an imbalance of the matrix degrading system. Eur J Pharmacol 630(1-3):145–151. https://doi.org/10.1016/j.ejphar.2009.12.019. S0014-2999(09)01140-6 [pii]

    Article  PubMed  Google Scholar 

  • Sawamura A, Okumura T, Hirakawa A, Ito M, Ozaki Y, Ohte N, Amano T, Murohara T, Investigators CP (2018) Early prediction model for successful bridge to recovery in patients with fulminant myocarditis supported with percutaneous venoarterial extracorporeal membrane oxygenation- insights from the CHANGE PUMP study. Circ J 82(3):699–707. https://doi.org/10.1253/circj.CJ-17-0549

    Article  PubMed  Google Scholar 

  • Schultheiss HP, Noutsias M, Kühl U, Pauschinger M (2006) Myocarditis and viral cardiomyopathy. In: Camm AJ, Lüscher TF, Serruys PW (Hrsg) The ESC textbook of cardiovascular medicine, Bd 1. Blackwell Publishing Ltd, Oxford, S 490–501

    Google Scholar 

  • Schultheiss HP, Piper C, Sowade O, Waagstein F, Kapp JF, Wegscheider K, Groetzbach G, Pauschinger M, Escher F, Arbustini E, Siedentop H, Kuehl U (2016a) Betaferon in chronic viral cardiomyopathy (BICC) trial: effects of interferon-beta treatment in patients with chronic viral cardiomyopathy. Clin Res Cardiol 105(9):763–773. https://doi.org/10.1007/s00392-016-0986-9

    Article  PubMed  Google Scholar 

  • Schultheiss HP, Piper C, Sowade O, Waagstein F, Kapp JF, Wegscheider K, Groetzbach G, Pauschinger M, Escher F, Arbustini E, Siedentop H, Kuehl U (2016b) Betaferon in chronic viral cardiomyopathy (BICC) trial: effects of interferon-β treatment in patients with chronic viral cardiomyopathy. Clin Res Cardiol 105(9):763–773. https://doi.org/10.1007/s00392-016-0986-9

    Article  PubMed  Google Scholar 

  • Seferovic PM, Polovina M, Bauersachs J, Arad M, Gal TB, Lund LH, Felix SB, Arbustini E, Caforio ALP, Farmakis D, Filippatos GS, Gialafos E, Kanjuh V, Krljanac G, Limongelli G, Linhart A, Lyon AR, Maksimovic R, Milicic D, Milinkovic I, Noutsias M, Oto A, Oto O, Pavlovic SU, Piepoli MF, Ristic AD, Rosano GMC, Seggewiss H, Asanin M, Seferovic JP, Ruschitzka F, Celutkiene J, Jaarsma T, Mueller C, Moura B, Hill L, Volterrani M, Lopatin Y, Metra M, Backs J, Mullens W, Chioncel O, de Boer RA, Anker S, Rapezzi C, Coats AJS, Tschope C (2019) Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 21(5):553–576. https://doi.org/10.1002/ejhf.1461

    Article  PubMed  Google Scholar 

  • Spillmann F, Van Linthout S, Schmidt G, Klein O, Hamdani N, Mairinger T, Krackhardt F, Maroski B, Schlabs T, Soltani S, Anker S, Potapov EV, Burkhoff D, Pieske B, Tschope C (2019) Mode-of-action of the PROPELLA concept in fulminant myocarditis. Eur Heart J 40(26):2164–2169. https://doi.org/10.1093/eurheartj/ehz124

    Article  PubMed  PubMed Central  Google Scholar 

  • Staudt A, Schaper F, Stangl V, Plagemann A, Bohm M, Merkel K, Wallukat G, Wernecke KD, Stangl K, Baumann G, Felix SB (2001) Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 103(22):2681–2686

    Article  PubMed  Google Scholar 

  • Staudt A, Bohm M, Knebel F, Grosse Y, Bischoff C, Hummel A, Dahm JB, Borges A, Jochmann N, Wernecke KD, Wallukat G, Baumann G, Felix SB (2002) Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation 106(19):2448–2453

    Article  PubMed  Google Scholar 

  • Staudt A, Hummel A, Ruppert J, Dorr M, Trimpert C, Birkenmeier K, Krieg T, Staudt Y, Felix SB (2006a) Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study. Am Heart J 152(4):712.e1–712.e6

    Article  PubMed  Google Scholar 

  • Staudt A, Staudt Y, Hummel A, Empen K, Dorr M, Trimpert C, Birkenmeier K, Kühl U, Noutsias M, Russ D, Felix SB (2006b) Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy. Ther Apher Dial 10(1):42–48

    Article  PubMed  Google Scholar 

  • Thomson RJ, Singh A, Knight DS, Buckley J, Lamb LE, Captur G (2021) Anakinra treats fulminant myocarditis from Neisseria meningitidis septicaemia and haemophagocytic lymphohistiocytosis: a case report. Eur Heart J Case Rep 5(6):ytab201. https://doi.org/10.1093/ehjcr/ytab201

    Article  PubMed  PubMed Central  Google Scholar 

  • Tschöpe C, Bock CT, Kasner M, Noutsias M, Westermann D, Schwimmbeck PL, Pauschinger M, Poller WC, Kühl U, Kandolf R, Schultheiss HP (2005) High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 111(7):879–886

    Article  PubMed  Google Scholar 

  • Tschope C, Elsanhoury A, Schlieker S, Van Linthout S, Kuhl U (2019) Immunosuppression in inflammatory cardiomyopathy and parvovirus B19 persistence. Eur J Heart Fail 21(11):1468–1469. https://doi.org/10.1002/ejhf.1560

    Article  PubMed  Google Scholar 

  • Why HJ, Meany BT, Richardson PJ, Olsen EG, Bowles NE, Cunningham L, Freeke CA, Archard LC (1994) Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 89(6):2582–2589

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Innere Medizin 8, Schwerpunkt Kardiologie, Universitätsklinik der Paracelsus Medizinischen Privatuniversität, Klinikum Nürnberg, Standort Süd, Nürnberg, Deutschland

    Matthias Pauschinger

  2. Medizinische Klinik A/Kardiologie, Angiologie, Nephrologie und Internistische Intensivmedizin, Universitätsklinikum Ruppin-Brandenburg (UKRB); Medizinische Hochschule Brandenburg (MHB) Theodor Fontane, Neuruppin, Deutschland

    Michel Noutsias

Authors
  1. Matthias Pauschinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michel Noutsias
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthias Pauschinger .

Editor information

Editors and Affiliations

  1. Medizinische Klinik I – Kardiologie, Angiologie und Internistische Intensivmedizin, Uniklinik RWTH Aachen, Aachen, Deutschland

    Nikolaus Marx

  2. Kardiologie, Pneumologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum Köln Klinik III für Innere Medizin, Köln, Deutschland

    Erland Erdmann

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Pauschinger, M., Noutsias, M. (2023). Myokarditis. In: Marx, N., Erdmann, E. (eds) Klinische Kardiologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-62932-1_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-62932-1_25

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-62931-4

  • Online ISBN: 978-3-662-62932-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation